Discussion Board Forums Clinical Trials Triphendiol clinical trial application filed

Viewing 1 post (of 1 total)
  • Author
  • #1780

    An application for a clinical trial has been filed for Triphendiol, which has orphan drug status, to be used as a chemosensitizing agent with gemcitabine.

    There is a lot to be hopeful for here, some of the highlights:

    -looks like the trial would be open to patients with unresectable, locally advanced or metastatic pancreatic and bile duct cancers (many trials exclude those with metastases)

    -orally delivered

    -exhibits high selectivity, little effect on non-tumor cells and no observable toxicity in animals at therapeutically effective doses

    -in human studies conducted in Australia, no adverse events or side effects have been reported

    Read the full press release here:


    Librarian Patty

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.